Is J.C. Penney Company, Inc. (JCP) Finding A Long Lost Shimmer? – ValueWalk Premium
01Jun

Is J.C. Penney Company, Inc. (JCP) Finding A Long Lost Shimmer?

With J.C. Penney Company, Inc. (NYSE:JCP) up 5 percent last week, has the department store turned a corner?


J.C. Penney up 5 percent in one week
While J.C. Penney Company, Inc. (NYSE:JCP) is still down over 1 percent on the year, the retail sector may experience a headwind from consumer confidence and the weather, according to a Sterne Agee report.
Sterne Agee notes consumer confidence, weather
Consumer confidence . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email support@valuewalk.com or click Chat.

Author

Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.

Related Posts

01Apr

Morgan Stanley: US Political Risk Underestimated By Markets

By

If one were to look at the broad stock market measures since the failure of the Trump health care bill March 24, the stock market has been positive, indicating... read more

ARCP
30Dec

Corvex Takes 7.1% Stake In ARCP, Seeks Board Seat

By

Keith Meister’s hedge fund firm Corvex Management LP disclosed Monday that it has accumulated a 7.1% stake in beleaguered real-estate investment trust American Realty Capital Properties Inc. The hedge fund... read more

22Nov

$2.5 Trillion Overseas? No And Cash Repatriations Could Start Bond Market Selloff

By

Cash Repatriations how much and what will be the impact Donald Trump’s election as president of the United States has rekindled the repatriation debate. One of the president elect’s campaign promises... read more

AENA
13Feb

Aena – Largest Euro IPO Since 2011 – A Quick Look At Valuation

By

By Jan Martínek Largest European IPO since 2011 up 21% since its launch Shares performed strongly despite the fact that there is no analyst report published yet Our valuation shows 30% further... read more

30Sep

Drug Shortages, Price Gouging, and Our Broken Health Care System

By

Drug Shortages, Price Gouging, and Our Broken Health Care System The shaming campaign that followed last week’s news of two generic drug prices somersaulting into the stratosphere after being acquired... read more

Europe
25Feb

Europe On Verge Of Deflation, But Equities Show Little Concern

By

The threat of deflation is growing, both in Europe and to a lesser extent in the US, and investors who have spent the last twenty years watching Japan try... read more

UK banks promoter score 0514 NUKEs
19May

NUKEs will Fundamentally Alter The UK banking Landscape

By

The Current Account Switch Guarantee, which went into effect in the UK last September, gives depositors an easy way to move from one bank to another. With the British... read more

Brexit, S&P 500
18Jun

Where The S&P 500 Faces Brexit Exposure

By

Where The S&P 500 Faces Brexit Exposure by John Butters, FactSet The United Kingdom will be a focus for the market during the upcoming week, as the country is scheduled... read more

06Dec

Alkeon Growth Partners: Tech Sector Could Become 50% of S&P 500

By

Alkeon Growth Partners LP returned 4.87% in November, taking its year-to-date gain for 2019 to 33.15%. For the year to the end of November, the MSCI World Index, the... read more

Valeant Pharmaceuticals earnings
04Sep

Valeant’s Acquires Medicis & Could Dominate The US Dermatology Market

By

Valeant Pharmaceuticals Int (NYSE:VRX) (TSE:VRX) announced on Labor Day, a deal to acquire Medicis Pharmaceutical Corp (NYSE:MRX) in a $2.6 billion deal. The Medicis shareholders would be paid $44 in cash... read more

X
Saved Articles
X
TextTExtLInkTextTExtLInk

Here’s a Tip: Read What Professional Investors Read

ValueWalk Premium is for investors looking to improve their investment process AND keep up-to-date on the latest industry trends.

It’s THE resource for value investing and hedge funds. 📈

And with a free three-day trial and $29.99 per month thereafter, it’s a value in its own right.

Sign up now. 👇

CLICK HERE TO TRY IT OUT

 

0